Completed
24-Hour Efficacy of TravoprostTimolol Benzalkonium Chloride BAK Free Compared With LatanoprostTimolol Fixed Combination Therapy in Subjects With Open-Angle Glaucoma Insufficiently Controlled With Latanoprost Monotherapy
Led by Aristotle University Of Thessaloniki · Updated on 2014-05-12
42
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
The primary objective of this crossover trial is to compare the 3-month, mean 24-hour intraocular pressure (IOP) control and safety obtained with two popular fixed combinations in glaucoma patients insufficiently controlled with latanoprost monotherapy. This study will compare the 24-hour efficacy of travoprost/timolol fixed combination without benzalkonium chloride given once in the evening, versus the latanoprost/timolol fixed combination given in the evening. It is assumed that travoprost/timolol fixed combination will provide better quality of 24-hour pressure control.
CONDITIONS
Brief Title
Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here